Literature DB >> 33504014

Gene Expression in Pancreatic Cancer-Like Cells and Induced Pancreatic Stem Cells Generated by Transient Overexpression of Reprogramming Factors.

Chika Miyagi-Shiohira1, Issei Saitoh2, Masami Watanabe3, Hirofumi Noguchi1.   

Abstract

We previously reported that transient overexpression of reprogramming factors can be used to generate induced pluripotent stem (iPS) cells, induced tissue-specific stem (iTS) cells, and fibroblast-like (iF) cells from pancreatic tissue. iF cells have tumorigenic ability and behave similarly to pancreatic cancer cells. In this study, we analyzed gene expression in iF cells and iTS-P cells (iTS cells from pancreatic tissue) via microarray analysis and quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The expression levels of the Mybl2 and Lyn genes, which are reported to be oncogenes, were significantly higher in iF cells than in iTS-P cells. The expression level of Nestin, which is expressed in not only pancreatic progenitor cells but also pancreatic ductal adenocarcinomas, was also higher in iF cells than in iTS-P cells. Itgb6 and Fgf13, which are involved in the pathogenesis of diseases such as cancer, exhibited higher expression levels in iF cells than in iTS-P cells. Unexpectedly, the expression levels of genes related to epithelial-mesenchymal transition (EMT), except Bmp4, were lower in iF cells than in iTS-P cells. These data suggest that the Mybl2, Lyn, Nestin, Itgb6, and Fgf13 genes could be important biomarkers to distinguish iTS-P cells from iF cells.

Entities:  

Keywords:  epithelial-mesenchymal transition (EMT); induced fibroblast-like (iF) cells; induced pluripotent stem (iPS) cells; induced tissue-specific stem (iTS) cells; pancreatic cancer; reprogramming factors

Year:  2021        PMID: 33504014      PMCID: PMC7865593          DOI: 10.3390/jcm10030454

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  54 in total

1.  Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells.

Authors:  Yuki Ohi; Han Qin; Chibo Hong; Laure Blouin; Jose M Polo; Tingxia Guo; Zhongxia Qi; Sara L Downey; Philip D Manos; Derrick J Rossi; Jingwei Yu; Matthias Hebrok; Konrad Hochedlinger; Joseph F Costello; Jun S Song; Miguel Ramalho-Santos
Journal:  Nat Cell Biol       Date:  2011-04-17       Impact factor: 28.824

2.  A more efficient method to generate integration-free human iPS cells.

Authors:  Keisuke Okita; Yasuko Matsumura; Yoshiko Sato; Aki Okada; Asuka Morizane; Satoshi Okamoto; Hyenjong Hong; Masato Nakagawa; Koji Tanabe; Ken-ichi Tezuka; Toshiyuki Shibata; Takahiro Kunisada; Masayo Takahashi; Jun Takahashi; Hiroh Saji; Shinya Yamanaka
Journal:  Nat Methods       Date:  2011-04-03       Impact factor: 28.547

3.  Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis.

Authors:  Kazuya Yamahatsu; Yoko Matsuda; Toshiyuki Ishiwata; Eiji Uchida; Zenya Naito
Journal:  Int J Oncol       Date:  2012-01-13       Impact factor: 5.650

4.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

5.  Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1.

Authors:  Andre B Choo; Heng Liang Tan; Sheu Ngo Ang; Wey Jia Fong; Angela Chin; Jennifer Lo; Lu Zheng; Hannes Hentze; Robin J Philp; Steve K W Oh; Miranda Yap
Journal:  Stem Cells       Date:  2008-03-20       Impact factor: 6.277

6.  Wnt5 signaling in vertebrate pancreas development.

Authors:  Hyon J Kim; Jack R Schleiffarth; Jose Jessurun; Saulius Sumanas; Anna Petryk; Shuo Lin; Stephen C Ekker
Journal:  BMC Biol       Date:  2005-10-24       Impact factor: 7.431

7.  Upregulated expression of FGF13/FHF2 mediates resistance to platinum drugs in cervical cancer cells.

Authors:  Tomoko Okada; Kazuhiro Murata; Ryoma Hirose; Chie Matsuda; Tsunehiko Komatsu; Masahiko Ikekita; Miyako Nakawatari; Fumiaki Nakayama; Masaru Wakatsuki; Tatsuya Ohno; Shingo Kato; Takashi Imai; Toru Imamura
Journal:  Sci Rep       Date:  2013-10-11       Impact factor: 4.379

Review 8.  MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis.

Authors:  Julian Musa; Marie-Ming Aynaud; Olivier Mirabeau; Olivier Delattre; Thomas Gp Grünewald
Journal:  Cell Death Dis       Date:  2017-06-22       Impact factor: 8.469

9.  In vivo reprogramming drives Kras-induced cancer development.

Authors:  Hirofumi Shibata; Shingo Komura; Yosuke Yamada; Nao Sankoda; Akito Tanaka; Tomoyo Ukai; Mio Kabata; Satoko Sakurai; Bunya Kuze; Knut Woltjen; Hironori Haga; Yatsuji Ito; Yoshiya Kawaguchi; Takuya Yamamoto; Yasuhiro Yamada
Journal:  Nat Commun       Date:  2018-05-25       Impact factor: 14.919

10.  Tissue-Specific Stem Cells Obtained by Reprogramming of Non-Obese Diabetic (NOD) Mouse-Derived Pancreatic Cells Confer Insulin Production in Response to Glucose.

Authors:  Issei Saitoh; Masahiro Sato; Miki Soda; Emi Inada; Yoko Iwase; Tomoya Murakami; Hayato Ohshima; Haruaki Hayasaki; Hirofumi Noguchi
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.